We follow the rule, the people shaping it, and the market it creates.

Evidence labels

Confirmed fact

Supported by a primary government, regulatory, or statutory source.

Company-reported fact

Reported by the facility, health system, or company, not independently validated.

PolicySight assessment

Commercial interpretation, account ranking, or recommended action.

Inference

A reasoned conclusion that still requires account level diligence.

Unverified

Named in the research but not confirmed against a primary source yet.

Verification standard

• Every trigger is tied to a statute, rule, agency release or budget instruction with a date.
• Current law and pending legislation are labeled separately and never blended.
• Facility status is taken from primary or facility published sources.
• Incumbent provider status and procurement intent are treated as unverified until confirmed.

Regulatory triggers, deadlines and facility status were checked against primary government, statutory and facility sources. Incumbent provider status and current water management program status were not verified at the account level.

Policy pathway and actor labels

These labels identify who controls the next step, where the decision sits, and when engagement may matter.

PolicySight Lobbying Intelligence

PolicySight combines cited public evidence with non-public relationship, process, stakeholder, and engagement context brought to us through our lobbying team.

Relationship context

Relevant relationship and prior engagement context, disclosed only where appropriate.

Process intelligence

Committee, agency, staff, and implementation dynamics around the next decision.

Stakeholder positioning

Industry, association, coalition, operator, and other stakeholder views where available.

Engagement timing

Practical windows for outreach before decisions, guidance, or implementation choices harden.

Proprietary intelligence can inform actor mapping, timing, engagement strategy, and confidence, but it does not replace verification of statutes, rules, deadlines, or public agency actions.

Sylmar fit context

Sylmar platform

Cooling and boiler water treatment, Legionella testing and remediation, water management program development and review, corrosion control, chemical programs, engineered pretreatment, wastewater systems, reverse osmosis, ultrafiltration, recycling, remote monitoring, and discharge compliance support.

Tower Water

Legionella management and mitigation, building and HVAC water treatment, pipe flushing and commissioning across NYC, NJ, eastern PA and southern CT, serving CRE, residential high rises, healthcare, pharmaceutical, data center, education and industrial customers.

Clearwater

Boiler, cooling tower, closed loop, softening and RO pretreatment programs, glycol engineering, and Legionella risk management services.

Butler Water Corrections

New Jersey based service for heating and cooling systems across institutional, commercial, hospitality, government and industrial applications.

ProChem

Industrial and commercial water and wastewater treatment with engineered reuse systems.

ETI portfolio note

ETI launched COOLGARD nonphosphorus cooling water chemistry on 31 Jul 2026. This research did not identify a specific 2025 or 2026 phosphorus rule or permit change that traces to named accounts, so it is noted as portfolio context only and not presented as a regulation created sales lane.

Public source register